C WorldWide Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

C WorldWide Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,109	Closed	-$73K	–	130
2017 Q2	$73K	Sell	1,109 -95	-8%	-$11.8K	﹤0.01%	129
2017 Q1	$261K	Buy	+1,204	New	+$172K	﹤0.01%	115
2016 Q3	–	Sell	-1,471	Closed	-$149K	–	127
2016 Q2	$149K	Hold	1,471	–	–	﹤0.01%	115
2016 Q1	$241K	Hold	1,471	–	–	﹤0.01%	118
2015 Q4	$482K	Hold	1,471	–	–	0.01%	123
2015 Q3	$474K	Buy	1,471 +27	+2%	+$11.9K	0.01%	125
2015 Q2	$576K	Hold	1,444	–	–	0.01%	122
2015 Q1	$711K	Buy	+1,444	New	+$560K	0.01%	96
2014 Q4	–	Sell	-7,000	Closed	-$1.41M	–	138
2014 Q3	$1.41M	Buy	+7,000	New	+$1.54M	0.02%	86

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

C WorldWide Group's LUMO Position: Q3 2017 in Review

C WorldWide Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 1,109 shares — an estimated $73K sold.

C WorldWide Group first reported a position in LUMO in Q3 2014 and held it in 9 quarters. The position peaked at $1.41M in Q3 2014. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

C WorldWide Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
C WorldWide Group sold 1,109 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $73K.
C WorldWide Group first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and held it in 9 quarters.
C WorldWide Group's Lumos Pharma, Inc. Common Stock position peaked at $1.41M in Q3 2014.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on C WorldWide Group's 13F filing for Q3 2017, filed 6 Nov 2017.